Companion Animal Diagnostics Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Consumables and Instruments), Companion Animal (Dogs, Cats, Horses, and Others), Technology (Imm

According to our new research study on “Companion Animal Diagnostics Market Forecast to 2031 -Global Analysis - by Product, Companion Animal, Technology, Application, End User, and Geography,” the market is anticipated to grow from US$ 4.61 billion in 2024 and is projected to reach US$ 8.80 billion by 2031; it is expected to register a CAGR of 9.8% during 2025-2031. The upsurging companion animal healthcare expenditure and the growing pet humanization and ownership are contributing to the growing companion animal diagnostics market size. However, the high cost of diagnostic products and infrastructure hampers the companion animal diagnostics market growth. Further, integrating digitalization and artificial intelligence in veterinary healthcare is expected to bring in new companion animal diagnostics market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for companion animal diagnostics in the world.

The US companion animal diagnostics market is growing, driven by increasing pet ownership, rising veterinary healthcare expenditures, and advancements in diagnostic technologies. Consumables, such as reagents and test kits, maintain a higher market share due to the rising prevalence of various diseases in companion animals. A surge in pet ownership has been observed in the US. According to the National Pet Owners Survey 2021-2022 by The American Pet Products Association, the pet population in the US has reached an exceptional high, with ~70% of households (~91 million homes) currently owning a pet. Similarly, according to NielsenIQ data, pet owners in the US spent US$ 66 billion on their pets in 2022. Moreover, as per the data of the American Pet Product Association in 2023, pet ownership is rising, with 90 million dogs in the US. This surge in pet ownership is driven by increasing societal dynamics and more understanding of pet companionship's emotional and health benefits. This has led to a substantial increase in the demand for advanced diagnostic services to detect, monitor, and manage the growing spectrum of chronic diseases affecting companion animals. The rise in the pet population and the increasing incidence of pet diseases, which require various diagnostic procedures for accurate diagnosis and treatment of chronic and acute diseases, drive the companion animal diagnostics market growth in the US.

Companion animal diagnostics Market Analysis

Strategic Initiatives by Market Players to Provide Market Opportunities in Future

Companies operating in the companion animal diagnostics market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them improve their sales, increase their geographic reach, and reinforce their capacities to cater to a greater than existing customer base. A few strategic initiatives by key players operating in the companion animal diagnostics market are mentioned below.

In March 2025, Antech launched truRapid FOUR, an exhaustive in-house canine vector-borne disease (CVBD) screening test. truRapid FOUR is a lateral flow test used to detect canine antibodies to Anaplasma spp., Ehrlichia spp., and Lyme C6 (Borrelia burgdorferi), as well as heartworm (Dirofilaria immitis) antigen, using whole blood, serum, or plasma.
In December 2024, Zoetis Inc. introduced its new screenless point-of-care hematology analyzer, Vetscan OptiCell. It is the foremost cartridge-based, AI-powered diagnostic tool for veterinary hematology. It provides complete blood count (CBC) analysis for precise insights.
In July 2024, EKF Diagnostics launched the Biosen C-Line, the latest glucose and lactate analyzer invented for improved usability. It features a touch screen and enhanced connectivity choices to incorporate seamlessly with hospital and lab IT systems via EKF Link. This benchtop analyzer provides exact glucose and lactate measurements, used in clinical settings for diabetes management and by elite sports teams for tracking lactate production in training.
In February 2024, MiDOG Animal Diagnostics launched a breakthrough all-in-one diagnostic test capable of rapidly diagnosing fungal and bacterial infections, including antibiotic resistance, across various animal species. The test aims to replace traditional testing procedures with efficient molecular-based diagnostics and subsidize extensive treatment strategies for diverse animals.
In April 2023, Mars Incorporated acquired Heska Corporation, a global leader in state-of-the-art veterinary diagnostic and specialty products.
In September 2022, Zomedica (a veterinary health company) launched its newest assay—Free T4 (fT4)—for the TRUFORMA In-Clinic Biosensor Testing Platform.
In August 2022, PepiPets launched its latest mobile diagnostic testing service, which allows clients to receive diagnostic testing for their pets at home.

Therefore, product launches, approvals, and collaborations are expected to create ample opportunities for the growth of the companion animal diagnostics market in the coming years.

Companion Animal Diagnostics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the companion animal diagnostics market analysis are equipment and end user.
Based on product, the companion animal diagnostics market is segmented into consumables and instruments. The consumables segment held the largest companion animal diagnostics market share in 2024.
Based on companion animal, the companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest companion animal diagnostics market share in 2024.
Based on technology, the companion animal diagnostics market is segmented into immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, urinalysis, and others. The immunodiagnostics segment held the largest companion animal diagnostics market share in 2024.
In terms of application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, parasitology, virology, and others. The clinical pathology segment dominated the market in 2024.
In terms of end user, the companion animal diagnostics market is segmented into diagnostic and reference laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment dominated the market in 2024.

Companion animal diagnostics Market: Competitive Landscape and Key Developments

ARI Medical Technology Co., Ltd., Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co., Ltd, Zoetis Inc., Demeditec Diagnostics GmbH, Idexx Laboratories, i-SENS Inc., Elabscience Biotechnology Inc., Universal Biosensors Inc., and Immunology Consultants Laboratory Inc. are among the key companies operating in the companion animal diagnostics market.

The Indian Veterinary Research Institute (IVRI), Animal Medicines Australia, American Veterinary Medical Association (AVMA), National Animal Health Monitoring System (NAHMS), Canadian Food Inspection Agency (CFIA), Assistance Dogs International (ADI), Directorate-General for Food (DGAL), and French National Animal Health Surveillance Platform (NAHSP), and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the companion animal diagnostics market report.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the companion animal diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the companion animal diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the companion animal diagnostics market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more